Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Maintains Outperform on Salesforce, Raises Price Target to $220

Wedbush Maintains Outperform on Salesforce, Raises Price Target to $220

Wedbush analyst Daniel Ives maintains Salesforce (NYSE:CRM) with a Outperform and raises the price target from $200 to $220.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Wedbush analyst Daniel Ives maintains Salesforce (NYSE:CRM) with a Outperform and raises the price target from $200 to $220.

HSBC Maintains Buy on Trip.com Group, Raises Price Target to $48

By Benzinga Newsdesk

March 8, 10:20 AM

HSBC analyst Parash Jain maintains Trip.com Group (NASDAQ:TCOM) with a Buy and raises the price target from $44 to $48.

TCOM

Oppenheimer Holdings Announces Share Repurchase Program To Repurchase Up To 536.5K Shares Of Common Stock

By Michael Horton

July 29, 4:18 PM

Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors approved a share repurchase program that authorizes the Company to purchase up to 536,500 shares of the Company's Class A non-voting

OPY

The Art Of The Future: Lisa Ray’s TheUpsideSpace Bring NFTs To Center Stage

By Mehab Qureshi

May 9, 10:02 AM

This article was orignally published on the Benzinga India portal.

$DOGE

UnitedHealth Delivers Q3 Earnings Beat, Issues Marginal Raise In Annual Profit Outlook

By Vandana Singh

October 13, 7:35 AM

UnitedHealth Group Inc (NYSE: UNH) reported nearly $5.8 billion, up

UNH

Wedbush Maintains Outperform on Salesforce, Raises Price Target to $220

Related Posts

HSBC Maintains Buy on Trip.com Group, Raises Price Target to $48

Oppenheimer Holdings Announces Share Repurchase Program To Repurchase Up To 536.5K Shares Of Common Stock

The Art Of The Future: Lisa Ray’s TheUpsideSpace Bring NFTs To Center Stage

UnitedHealth Delivers Q3 Earnings Beat, Issues Marginal Raise In Annual Profit Outlook